Open original FDA record ↗Recall record
- FDA identifier
- Z-0126-2011
- Company in FDA record
- Hospira, Inc.
- FDA classification date
- Oct 22, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The EndoTool software did not always provide an audible alert when a blood glucose measurement was due. This could result in a patient not receiving an appropriate dose of insulin.
Source facts
- Action
- Hospira issued an Urgent Device Field Correction letter dated July 23, 2010 to consignees, providing details of the potential issue and the associated patient risk. Hospira is finalizing software enhancements which will resolve this situation within the next 90 days ,and will contact each consignee when it is available to be downloaded from the Hospira website. The notification letter also included a clinical bulletin, outlining mitigation instructions for clinicians to use until the software enhancement is available. Consignees were requested to complete and return an attached Reply Form by fax. Customers can contact the Hospira EndoTool support line at 1-877-349-4582 for clinical inquiries about this recall.
- Initiated
- 2010-07-26
- Root cause
- Other
- Terminated
- 2014-02-25
- Distribution
- Nationwide Distribution in states of CA, FL, IL, IN, KY, KS, MI, MO, MT, NC, NJ, NM, NV, OH, SC, SD, TN, TX, VA, WA, and WY.
- Recall number
- Z-0126-2011
- Recall status
- Terminated
- CDRH record ID
- 94387
- FDA classified
- 2010-10-22
- Recall event number
- 56730